Epstein–Barr Virus and Breast Cancer
Author Information
Author(s): Xue S A, Lampert I A, Haldane J S, Bridger J E, Griffin B E
Primary Institution: Imperial College Faculty of Medicine at St Mary's
Hypothesis
Is Epstein–Barr virus (EBV) a contributing factor to breast cancer development?
Conclusion
The study found that 40% of breast cancer samples expressed EBV genes, suggesting a potential role of EBV in breast cancer.
Supporting Evidence
- 40% of the breast cancer samples examined were found to carry the EBV genome.
- All EBV-positive tumors expressed the CST/BART and LF3/IR4 transcripts.
- Three out of six EBV-positive tumors expressed the BARF1 gene.
- EBNA1 expression was found in three out of six tumors.
- EBV was detected in a significant number of breast cancer cases, suggesting its potential role in malignancy.
Takeaway
This study looked at breast cancer samples to see if a virus called EBV was involved, and they found it in some of the tumors.
Methodology
Seventeen tumor biopsy samples were collected from patients, and molecular analyses were performed to detect EBV gene expression.
Potential Biases
Potential bias due to the selection of samples from a single hospital and the focus on specific viral genes.
Limitations
The study was limited to a small sample size from a single hospital, which may not represent the broader population.
Participant Demographics
Median patient age was 62 years, with a majority being Caucasian and having ductal carcinomas.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website